CD68 as a multi-omic prognostic biomarker in digestive system cancers: correlations with tumor-infiltrating immune cells and immune checkpoints

Background and objectiveCD68 plays a crucial role in promoting phagocytosis. However, its expression level, prognostic value and the correlations with tumor-infiltrating immune cells (TIICs) or common tumor immune checkpoints (TICs) in human digestive system cancers (DSC) remain poorly understood. T...

Full description

Saved in:
Bibliographic Details
Main Authors: Hui Li, Hui Zhang, Rujiang Dai, Dian Zheng, Jianghai Zhao, Hong Jing, Xuhui Ma, Lin Zhang, Weihong Sun, Zhimin Suo
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1599677/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849232652125601792
author Hui Li
Hui Zhang
Rujiang Dai
Dian Zheng
Jianghai Zhao
Hong Jing
Xuhui Ma
Lin Zhang
Weihong Sun
Zhimin Suo
author_facet Hui Li
Hui Zhang
Rujiang Dai
Dian Zheng
Jianghai Zhao
Hong Jing
Xuhui Ma
Lin Zhang
Weihong Sun
Zhimin Suo
author_sort Hui Li
collection DOAJ
description Background and objectiveCD68 plays a crucial role in promoting phagocytosis. However, its expression level, prognostic value and the correlations with tumor-infiltrating immune cells (TIICs) or common tumor immune checkpoints (TICs) in human digestive system cancers (DSC) remain poorly understood. This study aims to investigate the expression levels, prognostic significance, and clinical implications of CD68, as well as its correlations with six TIICs and four common TICs in DSC.Materials and methodsWe analyzed CD68 mRNA and protein expression using online databases and immunohistochemistry (IHC) on tissue microarray (TMA) sections, comparing DSC tumor tissues with adjacent normal tissues. Overall survival (OS) was calculated to evaluate the prognostic value of CD68 in DSC. Additionally, correlations between CD68 expression and six TIICs (B cells, CD4+ T cells, CD8+ T cells, macrophages, NK cells, and cancer-associated fibroblasts) or four common TICs (PDCD1, CTLA4, IDO1, and CD40) were assessed using the Tumor Immune Estimation Resource (TIMER).ResultsCD68 mRNA expression was significantly higher in esophageal carcinoma (ESCA) and stomach adenocarcinoma (STAD) tissues compared to adjacent normal tissues, but lower in colon adenocarcinoma (COAD), liver hepatocellular carcinoma (LIHC), and pancreas invasive ductal carcinoma (PAAD). Protein expression of CD68 was significantly higher in COAD than in adjacent normal tissues, but lower in ESCA, LIHC, PAAD, and STAD. CD68 protein expression served as a prognostic marker in COAD and STAD. Furthermore, CD68 expression showed strong positive correlations with the six TIICs and significant positive correlations with the four TICs in DSC.ConclusionCD68 may serve as an essential prognostic biomarker in COAD and STAD and could be a promising candidate for diagnostic, prognostic, and therapeutic targeting in human DSC.
format Article
id doaj-art-cb01db39190f484eb849b84fcc519b1f
institution Kabale University
issn 1664-3224
language English
publishDate 2025-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-cb01db39190f484eb849b84fcc519b1f2025-08-21T04:10:25ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-08-011610.3389/fimmu.2025.15996771599677CD68 as a multi-omic prognostic biomarker in digestive system cancers: correlations with tumor-infiltrating immune cells and immune checkpointsHui Li0Hui Zhang1Rujiang Dai2Dian Zheng3Jianghai Zhao4Hong Jing5Xuhui Ma6Lin Zhang7Weihong Sun8Zhimin Suo9Department of Digestion, Huaihe Hospital of Henan University, Kaifeng, ChinaDepartment of Digestion, Huaihe Hospital of Henan University, Kaifeng, ChinaDepartment of Digestion, Huaihe Hospital of Henan University, Kaifeng, ChinaDepartment of Digestion, Huaihe Hospital of Henan University, Kaifeng, ChinaDepartment of Digestion, Huaihe Hospital of Henan University, Kaifeng, ChinaDepartment of Pathology, Huaihe Hospital of Henan University, Kaifeng, ChinaDepartment of Digestion, Huaihe Hospital of Henan University, Kaifeng, ChinaDepartment of Medical Equipment, Huaihe Hospital of Henan University, Kaifeng, ChinaDepartment of Digestion, Huaihe Hospital of Henan University, Kaifeng, ChinaDepartment of Digestion, Huaihe Hospital of Henan University, Kaifeng, ChinaBackground and objectiveCD68 plays a crucial role in promoting phagocytosis. However, its expression level, prognostic value and the correlations with tumor-infiltrating immune cells (TIICs) or common tumor immune checkpoints (TICs) in human digestive system cancers (DSC) remain poorly understood. This study aims to investigate the expression levels, prognostic significance, and clinical implications of CD68, as well as its correlations with six TIICs and four common TICs in DSC.Materials and methodsWe analyzed CD68 mRNA and protein expression using online databases and immunohistochemistry (IHC) on tissue microarray (TMA) sections, comparing DSC tumor tissues with adjacent normal tissues. Overall survival (OS) was calculated to evaluate the prognostic value of CD68 in DSC. Additionally, correlations between CD68 expression and six TIICs (B cells, CD4+ T cells, CD8+ T cells, macrophages, NK cells, and cancer-associated fibroblasts) or four common TICs (PDCD1, CTLA4, IDO1, and CD40) were assessed using the Tumor Immune Estimation Resource (TIMER).ResultsCD68 mRNA expression was significantly higher in esophageal carcinoma (ESCA) and stomach adenocarcinoma (STAD) tissues compared to adjacent normal tissues, but lower in colon adenocarcinoma (COAD), liver hepatocellular carcinoma (LIHC), and pancreas invasive ductal carcinoma (PAAD). Protein expression of CD68 was significantly higher in COAD than in adjacent normal tissues, but lower in ESCA, LIHC, PAAD, and STAD. CD68 protein expression served as a prognostic marker in COAD and STAD. Furthermore, CD68 expression showed strong positive correlations with the six TIICs and significant positive correlations with the four TICs in DSC.ConclusionCD68 may serve as an essential prognostic biomarker in COAD and STAD and could be a promising candidate for diagnostic, prognostic, and therapeutic targeting in human DSC.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1599677/fullCD68digestive system cancersmacrophageprognosisbiomarkerimmune checkpoint
spellingShingle Hui Li
Hui Zhang
Rujiang Dai
Dian Zheng
Jianghai Zhao
Hong Jing
Xuhui Ma
Lin Zhang
Weihong Sun
Zhimin Suo
CD68 as a multi-omic prognostic biomarker in digestive system cancers: correlations with tumor-infiltrating immune cells and immune checkpoints
Frontiers in Immunology
CD68
digestive system cancers
macrophage
prognosis
biomarker
immune checkpoint
title CD68 as a multi-omic prognostic biomarker in digestive system cancers: correlations with tumor-infiltrating immune cells and immune checkpoints
title_full CD68 as a multi-omic prognostic biomarker in digestive system cancers: correlations with tumor-infiltrating immune cells and immune checkpoints
title_fullStr CD68 as a multi-omic prognostic biomarker in digestive system cancers: correlations with tumor-infiltrating immune cells and immune checkpoints
title_full_unstemmed CD68 as a multi-omic prognostic biomarker in digestive system cancers: correlations with tumor-infiltrating immune cells and immune checkpoints
title_short CD68 as a multi-omic prognostic biomarker in digestive system cancers: correlations with tumor-infiltrating immune cells and immune checkpoints
title_sort cd68 as a multi omic prognostic biomarker in digestive system cancers correlations with tumor infiltrating immune cells and immune checkpoints
topic CD68
digestive system cancers
macrophage
prognosis
biomarker
immune checkpoint
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1599677/full
work_keys_str_mv AT huili cd68asamultiomicprognosticbiomarkerindigestivesystemcancerscorrelationswithtumorinfiltratingimmunecellsandimmunecheckpoints
AT huizhang cd68asamultiomicprognosticbiomarkerindigestivesystemcancerscorrelationswithtumorinfiltratingimmunecellsandimmunecheckpoints
AT rujiangdai cd68asamultiomicprognosticbiomarkerindigestivesystemcancerscorrelationswithtumorinfiltratingimmunecellsandimmunecheckpoints
AT dianzheng cd68asamultiomicprognosticbiomarkerindigestivesystemcancerscorrelationswithtumorinfiltratingimmunecellsandimmunecheckpoints
AT jianghaizhao cd68asamultiomicprognosticbiomarkerindigestivesystemcancerscorrelationswithtumorinfiltratingimmunecellsandimmunecheckpoints
AT hongjing cd68asamultiomicprognosticbiomarkerindigestivesystemcancerscorrelationswithtumorinfiltratingimmunecellsandimmunecheckpoints
AT xuhuima cd68asamultiomicprognosticbiomarkerindigestivesystemcancerscorrelationswithtumorinfiltratingimmunecellsandimmunecheckpoints
AT linzhang cd68asamultiomicprognosticbiomarkerindigestivesystemcancerscorrelationswithtumorinfiltratingimmunecellsandimmunecheckpoints
AT weihongsun cd68asamultiomicprognosticbiomarkerindigestivesystemcancerscorrelationswithtumorinfiltratingimmunecellsandimmunecheckpoints
AT zhiminsuo cd68asamultiomicprognosticbiomarkerindigestivesystemcancerscorrelationswithtumorinfiltratingimmunecellsandimmunecheckpoints